0.54
-0.0045(-0.82%)
Currency In USD
| Previous Close | 0.55 |
| Open | 0.53 |
| Day High | 0.55 |
| Day Low | 0.53 |
| 52-Week High | 1.8 |
| 52-Week Low | 0.31 |
| Volume | 165,766 |
| Average Volume | 1.34M |
| Market Cap | 15.95M |
| PE | -0.78 |
| EPS | -0.69 |
| Moving Average 50 Days | 0.66 |
| Moving Average 200 Days | 0.74 |
| Change | -0 |
If you invested $1000 in Femasys Inc. (FEMY) since IPO date, it would be worth $45.12 as of February 21, 2026 at a share price of $0.542. Whereas If you bought $1000 worth of Femasys Inc. (FEMY) shares 3 years ago, it would be worth $443.85 as of February 21, 2026 at a share price of $0.542.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
GlobeNewswire Inc.
Feb 03, 2026 2:15 PM GMT
-- Multi-Product Distribution Agreement Marks Continued Commercial Momentum in Europe --ATLANTA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
GlobeNewswire Inc.
Jan 14, 2026 2:00 PM GMT
ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (“Femasys” or the “Company”), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, tod
Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care
GlobeNewswire Inc.
Jan 13, 2026 2:00 PM GMT
Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large, engaged patient populationATLANTA , Jan. 13, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making f